How big is the basal insulin longacting insulin market?

When fasting the body steadily releases glucose into the blood to our cells supplied with energy.Market Analysis and Insights Global Basal Insulin LongActing Insulin MarketDue to the COVID19 pandemic the global Basal Insulin LongActing Insulin market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Global Basal Insulin Long Acting Insulin Market Insights Forecast to 2028

BUY CHAPTERS

Global Basal Insulin (Long-Acting Insulin) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Q: Who are the key players in the basal insulin longacting insulin market?

Some of the key players are Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon Ltd., Julphar, Exir, Sedico, WOCKHARDT, Others.

Code: QYRE-Auto-26I8164

Report

January 2023

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Basal Insulin (Long-Acting Insulin) manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Basal Insulin (Long-Acting Insulin) market. Further, it explains the major drivers and regional dynamics of the global Basal Insulin (Long-Acting Insulin) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Novo Nordisk

Sanofi Aventis

Eli Lilly

Biocon

Julphar

Exir

Sedico

Wockhardt

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Basal Insulin (Long-Acting Insulin) Segment by Type

Lantus

Levemir

Tresiba

Toujeo

Basaglar

Biosimilar Glargines

Basal Insulin (Long-Acting Insulin) Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Basal Insulin (Long-Acting Insulin) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Basal Insulin (Long-Acting Insulin), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Basal Insulin (Long-Acting Insulin), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Basal Insulin (Long-Acting Insulin), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Basal Insulin (Long-Acting Insulin) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Basal Insulin (Long-Acting Insulin) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Basal Insulin (Long-Acting Insulin) sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Lantus

1.2.3 Levemir

1.2.4 Tresiba

1.2.5 Toujeo

1.2.6 Basaglar

1.2.7 Biosimilar Glargines

1.3 Market Segment by Application

1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Share by Application (2017 VS 2021 VS 2028)

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Basal Insulin (Long-Acting Insulin) Market Size (2017-2028)

2.1.1 Global Basal Insulin (Long-Acting Insulin) Revenue (2017-2028)

2.1.2 Global Basal Insulin (Long-Acting Insulin) Sales (2017-2028)

2.2 Global Basal Insulin (Long-Acting Insulin) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Regions (2017-2022)

2.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Regions (2017-2022)

2.3 Global Basal Insulin (Long-Acting Insulin) Market Size Forecast by Region

2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2023-2028)

2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2023-2028)

2.4 Global Top Basal Insulin (Long-Acting Insulin) Regions (Countries) Ranking by Market Size

2.5 Basal Insulin (Long-Acting Insulin) Market Dynamics

2.5.1 Basal Insulin (Long-Acting Insulin) Market Trends

2.5.2 Basal Insulin (Long-Acting Insulin) Market Drivers

2.5.3 Basal Insulin (Long-Acting Insulin) Market Challenges

2.5.4 Basal Insulin (Long-Acting Insulin) Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Basal Insulin (Long-Acting Insulin) Manufacturers by Sales (2017-2022)

3.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (2017-2022)

3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global 5 and 10 Largest Manufacturers by Basal Insulin (Long-Acting Insulin) Sales in 2021

3.2 Global Top Manufacturers Basal Insulin (Long-Acting Insulin) by Revenue

3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2017-2022)

3.2.2 Top Basal Insulin (Long-Acting Insulin) Manufacturers Covered: Ranking by Revenue

3.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2017-2022)

3.2.4 Global Basal Insulin (Long-Acting Insulin) Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2021)

3.4 Global Basal Insulin (Long-Acting Insulin) Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Basal Insulin (Long-Acting Insulin) Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Basal Insulin (Long-Acting Insulin) Market

3.7 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Basal Insulin (Long-Acting Insulin) Market Size by Type

4.1 Global Basal Insulin (Long-Acting Insulin) Historic Market Review by Type (2017-2022)

4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2022)

4.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2022)

4.1.3 Basal Insulin (Long-Acting Insulin) Price by Type (2017-2022)

4.2 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts by Type (2023-2028)

4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2023-2028)

4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2023-2028)

4.2.3 Basal Insulin (Long-Acting Insulin) Price Forecast by Type (2023-2028)

5 Global Basal Insulin (Long-Acting Insulin) Market Size by Application

5.1 Global Basal Insulin (Long-Acting Insulin) Historic Market Review by Application (2017-2022)

5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2022)

5.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2022)

5.1.3 Basal Insulin (Long-Acting Insulin) Price by Application (2017-2022)

5.2 Global Basal Insulin (Long-Acting Insulin) Market Estimates and Forecasts by Application (2023-2028)

5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2023-2028)

5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2023-2028)

5.2.3 Basal Insulin (Long-Acting Insulin) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Company

6.1.1 North America Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022)

6.1.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022)

6.2 North America Basal Insulin (Long-Acting Insulin) Market Size by Type

6.2.1 North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)

6.2.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)

6.3 North America Basal Insulin (Long-Acting Insulin) Market Size by Application

6.3.1 North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)

6.3.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)

6.4 North America Basal Insulin (Long-Acting Insulin) Market Size by Country

6.4.1 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)

6.4.2 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Company

7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022)

7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022)

7.2 Europe Basal Insulin (Long-Acting Insulin) Market Size by Type

7.2.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)

7.2.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)

7.3 Europe Basal Insulin (Long-Acting Insulin) Market Size by Application

7.3.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)

7.3.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)

7.4 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country

7.4.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)

7.4.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Breakdown by Company

8.1.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022)

8.1.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022)

8.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Type

8.2.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)

8.2.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)

8.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Application

8.3.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)

8.3.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)

8.4 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region

8.4.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region

8.4.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 China Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

9 Latin America

9.1 Latin America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Company

9.1.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022)

9.1.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022)

9.2 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Type

9.2.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)

9.2.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)

9.3 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Application

9.3.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)

9.3.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)

9.4 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country

9.4.1 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)

9.4.2 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Breakdown by Company

10.1.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022)

10.1.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022)

10.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Type

10.2.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2028)

10.2.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2028)

10.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Application

10.3.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2028)

10.3.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2028)

10.4 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country

10.4.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2028)

10.4.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 Novo Nordisk

11.1.1 Novo Nordisk Corporation Information

11.1.2 Novo Nordisk Overview

11.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Products and Services

11.1.5 Novo Nordisk Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.1.6 Novo Nordisk Recent Developments

11.2 Sanofi Aventis

11.2.1 Sanofi Aventis Corporation Information

11.2.2 Sanofi Aventis Overview

11.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Products and Services

11.2.5 Sanofi Aventis Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.2.6 Sanofi Aventis Recent Developments

11.3 Eli Lilly

11.3.1 Eli Lilly Corporation Information

11.3.2 Eli Lilly Overview

11.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Products and Services

11.3.5 Eli Lilly Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.3.6 Eli Lilly Recent Developments

11.4 Biocon

11.4.1 Biocon Corporation Information

11.4.2 Biocon Overview

11.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.4.4 Biocon Basal Insulin (Long-Acting Insulin) Products and Services

11.4.5 Biocon Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.4.6 Biocon Recent Developments

11.5 Julphar

11.5.1 Julphar Corporation Information

11.5.2 Julphar Overview

11.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.5.4 Julphar Basal Insulin (Long-Acting Insulin) Products and Services

11.5.5 Julphar Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.5.6 Julphar Recent Developments

11.6 Exir

11.6.1 Exir Corporation Information

11.6.2 Exir Overview

11.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.6.4 Exir Basal Insulin (Long-Acting Insulin) Products and Services

11.6.5 Exir Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.6.6 Exir Recent Developments

11.7 Sedico

11.7.1 Sedico Corporation Information

11.7.2 Sedico Overview

11.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.7.4 Sedico Basal Insulin (Long-Acting Insulin) Products and Services

11.7.5 Sedico Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.7.6 Sedico Recent Developments

11.8 Wockhardt

11.8.1 Wockhardt Corporation Information

11.8.2 Wockhardt Overview

11.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Products and Services

11.8.5 Wockhardt Basal Insulin (Long-Acting Insulin) SWOT Analysis

11.8.6 Wockhardt Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Basal Insulin (Long-Acting Insulin) Value Chain Analysis

12.2 Basal Insulin (Long-Acting Insulin) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process

12.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing

12.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels

12.4.2 Basal Insulin (Long-Acting Insulin) Distributors

12.5 Basal Insulin (Long-Acting Insulin) Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Lantus

Table 3. Major Manufacturers of Levemir

Table 4. Major Manufacturers of Tresiba

Table 5. Major Manufacturers of Toujeo

Table 6. Major Manufacturers of Basaglar

Table 7. Major Manufacturers of Biosimilar Glargines

Table 8. Global Basal Insulin (Long-Acting Insulin) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 9. Global Basal Insulin (Long-Acting Insulin) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 10. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)

Table 11. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)

Table 12. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2017-2022)

Table 14. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2023-2028) & (K Units)

Table 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Region (2023-2028)

Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2023-2028) & (US$ Million)

Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2023-2028)

Table 18. Top Basal Insulin (Long-Acting Insulin) Regions (Countries) Ranking by Market Size (US$ Million) in 2021

Table 19. Basal Insulin (Long-Acting Insulin) Market Trends

Table 20. Basal Insulin (Long-Acting Insulin) Market Drivers

Table 21. Basal Insulin (Long-Acting Insulin) Market Challenges

Table 22. Basal Insulin (Long-Acting Insulin) Market Restraints

Table 23. Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (2017-2022) & (K Units)

Table 24. Global Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers (2017-2022)

Table 25. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 26. Ranking of Global Top Basal Insulin (Long-Acting Insulin) Manufacturers by Revenue (US$ Million) in 2021

Table 27. Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2017-2022)

Table 28. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2021)

Table 30. Key Manufacturers Basal Insulin (Long-Acting Insulin) Average Selling Price (ASP) & (2017-2022) & (US$/Unit)

Table 31. Key Manufacturers Basal Insulin (Long-Acting Insulin) Plants/Factories Distribution

Table 32. Key Manufacturers Basal Insulin (Long-Acting Insulin) Area Served

Table 33. Date of Key Manufacturers Enter into Basal Insulin (Long-Acting Insulin) Market

Table 34. Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Type

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2017-2022)

Table 37. Global Basal Insulin (Long-Acting Insulin) Sales Share by Type (2017-2022)

Table 38. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) Market Share by Type (2017-2022)

Table 39. Global Basal Insulin (Long-Acting Insulin) Price (K Units) by Type (2017-2022)

Table 40. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2023-2028)

Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Share by Type (2023-2028)

Table 42. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) Market Share by Type (2023-2028)

Table 43. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2023-2028)

Table 44. Global Basal Insulin (Long-Acting Insulin) Price (K Units) by Type (2023-2028)

Table 45. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2017-2022)

Table 46. Global Basal Insulin (Long-Acting Insulin) Sales Share by Application (2017-2022)

Table 47. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) Market Share by Application (2017-2022)

Table 48. Global Basal Insulin (Long-Acting Insulin) Price (K Units) by Application (2017-2022)

Table 49. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2023-2028)

Table 50. Global Basal Insulin (Long-Acting Insulin) Sales Share by Application (2023-2028)

Table 51. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) Market Share by Application (2023-2028)

Table 52. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2023-2028)

Table 53. Global Basal Insulin (Long-Acting Insulin) Price (K Units) by Application (2023-2028)

Table 54. North America Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022) & (K Units)

Table 55. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2017-2022)

Table 56. North America Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022) & (US$ Million)

Table 57. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2017-2022)

Table 58. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 59. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)

Table 60. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)

Table 61. North America Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)

Table 62. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 63. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)

Table 64. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)

Table 65. North America Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)

Table 66. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 67. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)

Table 68. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)

Table 69. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)

Table 70. Europe Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022) & (K Units)

Table 71. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2017-2022)

Table 72. Europe Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022) & (US$ Million)

Table 73. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2017-2022)

Table 74. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 75. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)

Table 76. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)

Table 77. Europe Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)

Table 78. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 79. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)

Table 80. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)

Table 81. Europe Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)

Table 82. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 83. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)

Table 84. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)

Table 85. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)

Table 86. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022) & (K Units)

Table 87. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2017-2022)

Table 88. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022) & (US$ Million)

Table 89. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2017-2022)

Table 90. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 91. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)

Table 92. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)

Table 93. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)

Table 94. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 95. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)

Table 96. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)

Table 97. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)

Table 98. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2017-2022) & (K Units)

Table 99. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2023-2028) & (K Units)

Table 100. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2017-2022) & (US$ Million)

Table 101. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2023-2028) & (US$ Million)

Table 102. Latin America Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022) & (K Units)

Table 103. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2017-2022)

Table 104. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022) & (US$ Million)

Table 105. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2017-2022)

Table 106. Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 107. Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)

Table 108. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)

Table 109. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)

Table 110. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 111. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)

Table 112. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)

Table 113. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)

Table 114. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 115. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)

Table 116. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)

Table 117. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)

Table 118. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Company (2017-2022) & (K Units)

Table 119. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2017-2022)

Table 120. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Company (2017-2022) & (US$ Million)

Table 121. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2017-2022)

Table 122. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2017-2022) & (K Units)

Table 123. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2023-2028) & (K Units)

Table 124. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2017-2022) & (US$ Million)

Table 125. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Type (2023-2028) & (US$ Million)

Table 126. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2017-2022) & (K Units)

Table 127. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2023-2028) & (K Units)

Table 128. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2017-2022) & (US$ Million)

Table 129. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Application (2023-2028) & (US$ Million)

Table 130. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2017-2022) & (K Units)

Table 131. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2023-2028) & (K Units)

Table 132. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2017-2022) & (US$ Million)

Table 133. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2023-2028) & (US$ Million)

Table 134. Novo Nordisk Corporation Information

Table 135. Novo Nordisk Description and Overview

Table 136. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 137. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product and Services

Table 138. Novo Nordisk Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 139. Novo Nordisk Recent Developments

Table 140. Sanofi Aventis Corporation Information

Table 141. Sanofi Aventis Description and Overview

Table 142. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 143. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product and Services

Table 144. Sanofi Aventis Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 145. Sanofi Aventis Recent Developments

Table 146. Eli Lilly Corporation Information

Table 147. Eli Lilly Description and Overview

Table 148. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 149. Eli Lilly Basal Insulin (Long-Acting Insulin) Product and Services

Table 150. Eli Lilly Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 151. Eli Lilly Recent Developments

Table 152. Biocon Corporation Information

Table 153. Biocon Description and Overview

Table 154. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 155. Biocon Basal Insulin (Long-Acting Insulin) Product and Services

Table 156. Biocon Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 157. Biocon Recent Developments

Table 158. Julphar Corporation Information

Table 159. Julphar Description and Overview

Table 160. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 161. Julphar Basal Insulin (Long-Acting Insulin) Product and Services

Table 162. Julphar Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 163. Julphar Recent Developments

Table 164. Exir Corporation Information

Table 165. Exir Description and Overview

Table 166. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 167. Exir Basal Insulin (Long-Acting Insulin) Product and Services

Table 168. Exir Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 169. Exir Recent Developments

Table 170. Sedico Corporation Information

Table 171. Sedico Description and Overview

Table 172. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 173. Sedico Basal Insulin (Long-Acting Insulin) Product and Services

Table 174. Sedico Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 175. Sedico Recent Developments

Table 176. Wockhardt Corporation Information

Table 177. Wockhardt Description and Overview

Table 178. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 179. Wockhardt Basal Insulin (Long-Acting Insulin) Product and Services

Table 180. Wockhardt Basal Insulin (Long-Acting Insulin) SWOT Analysis

Table 181. Wockhardt Recent Developments

Table 182. Key Raw Materials Lists

Table 183. Raw Materials Key Suppliers Lists

Table 184. Basal Insulin (Long-Acting Insulin) Distributors List

Table 185. Basal Insulin (Long-Acting Insulin) Customers List

Table 186. Research Programs/Design for This Report

Table 187. Key Data Information from Secondary Sources

Table 188. Key Data Information from Primary Sources

List of Figures

Figure 1. Basal Insulin (Long-Acting Insulin) Product Picture

Figure 2. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2021 & 2028

Figure 3. Lantus Product Picture

Figure 4. Levemir Product Picture

Figure 5. Tresiba Product Picture

Figure 6. Toujeo Product Picture

Figure 7. Basaglar Product Picture

Figure 8. Biosimilar Glargines Product Picture

Figure 9. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2021 & 2028

Figure 10. Type 1 Diabetes Use Case

Figure 11. Type 2 Diabetes Use Case

Figure 12. Basal Insulin (Long-Acting Insulin) Report Years Considered

Figure 13. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Basal Insulin (Long-Acting Insulin) Market Size 2017-2028 (US$ Million)

Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales (2017-2022) & (K Units)

Figure 16. Global Basal Insulin (Long-Acting Insulin) Market Size Market Share by Region: 2021 VS 2028

Figure 17. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2017-2022)

Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2021

Figure 19. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in 2017 VS 2021

Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2021

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Basal Insulin (Long-Acting Insulin) Sales in 2021

Figure 22. Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2021

Figure 23. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 24. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Type (2017-2022)

Figure 25. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate by Type in 2017 & 2021

Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Application (2017-2022)

Figure 27. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate by Application in 2017 & 2021

Figure 28. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)

Figure 29. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)

Figure 30. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)

Figure 31. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)

Figure 32. North America Basal Insulin (Long-Acting Insulin) Sales Share by Country (2017-2028)

Figure 33. North America Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2017-2028)

Figure 34. United States Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 35. Canada Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 36. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)

Figure 37. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)

Figure 38. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)

Figure 39. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)

Figure 40. Europe Basal Insulin (Long-Acting Insulin) Sales Share by Country (2017-2028)

Figure 41. Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2017-2028)

Figure 42. Germany Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 43. France Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 44. U.K. Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 45. Italy Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 46. Russia Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 47. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)

Figure 48. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)

Figure 49. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)

Figure 50. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)

Figure 51. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Share by Region (2017-2028)

Figure 52. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Share by Region (2017-2028)

Figure 53. China Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 54. Japan Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 55. South Korea Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 56. India Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 57. Australia Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 58. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 59. Indonesia Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 60. Thailand Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 61. Malaysia Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 62. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)

Figure 63. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)

Figure 64. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)

Figure 65. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)

Figure 66. Latin America Basal Insulin (Long-Acting Insulin) Sales Share by Country (2017-2028)

Figure 67. Latin America Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2017-2028)

Figure 68. Mexico Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 69. Brazil Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 70. Argentina Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 71. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Share by Country (2017-2028)

Figure 76. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Share by Country (2017-2028)

Figure 77. Turkey Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 78. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 79. UAE Basal Insulin (Long-Acting Insulin) Revenue (2017-2028) & (US$ Million)

Figure 80. Basal Insulin (Long-Acting Insulin) Value Chain

Figure 81. Basal Insulin (Long-Acting Insulin) Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Basal Insulin (Long-Acting Insulin) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: January 2023

Report Code: QYRE-Auto-26I8164

Global Basal Insulin (Long-Acting Insulin) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Basal Insulin (Long-Acting Insulin) Segment by Type

Basal Insulin (Long-Acting Insulin) Segment by Application

FEATURED COMPANIES